Maximum IgM concentrations in the first seven days after stroke were also assessed and did not significantly differ in IL-1Ra or placebo treated patients in comparison to non-stroke controls (Supplementary Figure 1A,Extended data)9. The gene discussed is CD40LG; the disease is Stroke.